Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izaf266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Andrew Suchan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States. Hauptthemen laut MEDLINE: Transgender Persons, Healthcare Disparities, Inflammatory Bowel Diseases, Patient Acceptance of Health Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Transgender and nonbinary (TGNB) individuals comprise 0.5% to 0.6% of the U.S. population and face significant healthcare disparities, yet little is known about inflammatory bowel disease (IBD) in this group. We aimed to characterize IBD prevalence, comorbidities, healthcare utilization, and the impact of hormone replacement therapy (HRT) in TGNB individuals.
Methods
Using TriNetX, we analyzed (1) IBD prevalence among TGNB adults, (2) comparisons of IBD patients who are and who are not TGNB, and (3) comparisons of TGNB IBD patients with and without HRT. Outcomes included demographics, comorbidities, laboratory markers, healthcare encounters, IBD treatment, and cardiovascular and thrombotic events.
Results
Of 111 227 TGNB patients, prevalence of Crohn’s disease and ulcerative colitis was 0.508% and 0.448%, respectively, increasing with age. TGNB patients were younger (32.5 years of age vs 46.9 years of age; P < .001), exhibited higher rates of gastrointestinal and psychiatric comorbidities, and had more outpatient, emergency, and hospital visits, yet they underwent fewer endoscopies (25.7% vs 30.7% risk; P = .011) and were less likely to receive targeted IBD therapy than cisgender patients. Patients with HRT had more outpatient encounters (66.7% vs 58.2%; P = .010) and were more likely to use therapies like mesalamine (12.4% vs 7.6%; P = .021) than those without HRT. There were no significant differences in laboratory markers or thrombotic or cardiovascular events in these analyses.
Conclusions
TGNB IBD patients experience greater gastrointestinal and psychiatric comorbidities and receive fewer interventions overall despite greater healthcare contact. HRT was not associated with worsening disease or complications. These findings highlight critical disparities and the need for further research in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Internal Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Division of Gastroenterology and Hepatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Plastic and Reconstructive Surgery, Center for Transgender and Gender Expansive Health, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.
ORCID-Profile: Andrew Suchan, Lara Chaaban, Lynn Kobeissi, Bashar A Hassan, Fan Liang, Sowmya Sharma, Joanna M Melia
Zitieren
APA
Suchan, A., Chaaban, L., Kobeissi, L., Hassan, B. A., Liang, F., Sharma, S., & Melia, J. M. (2026). Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf266
Vancouver
Suchan A, Chaaban L, Kobeissi L, Hassan BA, Liang F, Sharma S, et al. Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izaf266
BibTeX
@article{Suchan2026,
author = {Suchan, Andrew and Chaaban, Lara and Kobeissi, Lynn and Hassan, Bashar A and Liang, Fan and Sharma, Sowmya and Melia, Joanna M},
title = {Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izaf266}
}
EUVIMED